X0855259
Project Grant
Overview
Grant Description
RYAN WHITE PART B SUPPLEMENTAL - VIRGINIA, A MEDIUM-SIZED SOUTHEASTERN STATE, CONSISTS OF 95 COUNTIES AND 38 INDEPENDENT CITIES AND RANKED TWELFTH IN POPULATION SIZE. ITS POPULATION ESTIMATE IN 2023 OF 8,715,698 ACCOUNTED FOR 2.6% OF THE NATION’S TOTAL POPULATION OF OVER 334 MILLION. IN THE COMMONWEALTH OF VIRGINIA, THE VIRGINIA DEPARTMENT OF HEALTH (VDH) OVERSEES THE PUBLIC HEALTH SERVICES AND RESOURCES 39 HEALTH DISTRICTS AND 119 LOCAL HEALTH DEPARTMENTS. THE HIV CARE SERVICES UNIT, OVERSEEN BY THE DIVISION OF DISEASE PREVENTION IN THE OFFICE OF EPIDEMIOLOGY, ADMINISTERS THE RYAN WHITE HIV/AIDS PROGRAM PART B (RWHAP B). THE VDH SYSTEM DELIVERY SYSTEM FOCUSES ON IMPROVING EARLIER LINKAGE TO CARE, RETENTION IN CARE, AND VIRAL SUPPRESSION FOR LOW-INCOME HIV-POSITIVE CLIENTS. THE RWHAP B RECEIVES AN ANNUAL FORMULA AWARD OF APPROXIMATELY $8M, INCLUDING THE EMERGING COMMUNITIES FUNDS THE VDH ALLOCATES TO 36 UNIQUE SERVICE PROVIDERS AND VENDORS TO PROVIDE THE ALLOWABLE RWHAP SERVICES THROUGHOUT THE FIVE HEALTH REGIONS OF THE STATE. VIRGINIA ALSO RECEIVES ALMOST $18M ANNUALLY EARMARKED FOR THE AIDS DRUGS ASSISTANCE PROGRAM, ADAP, TO PROVIDE MEDICATION ACCESS FOR THE TREATMENT OF HIV AND RELATED ILLNESSES FOR ELIGIBLE CLIENTS. FUNDED SERVICES INCLUDE 21 ALLOWABLE CORE MEDICAL AND SUPPORT SERVICES, INCLUDING ADAP. THE VIRGINIA RWHAP B CURRENTLY PROVIDES NEARLY 8,700 PEOPLE WITH HIV (PWH) WITH CORE MEDICAL AND SUPPORT SERVICES FOR THEIR HIV CARE AND TREATMENT . IN GRANT YEAR 2023, VIRGINIA EXPENDED $57M IN CONTRACTS TO MEET THE NEEDS OF THE 8,444 PWH WITH THE MAJORITY GOING TO ADAP SERVICES FOR 4,175 PWH. CLIENTS MUST DEMONSTRATE AND MAINTAIN THEIR ELIGIBILITY FOR SERVICES. THE NETWORK OF PROVIDERS INCLUDES MEDICAL PROVIDERS, COMMUNITY-BASED ORGANIZATIONS, AIDS SERVICES ORGANIZATIONS, UNIVERSITY AND HOSPITAL HEALTH SYSTEMS, FREE CLINICS, AND FEDERALLY QUALIFIED HEALTH CENTERS AND LOOK-ALIKES. DEMOGRAPHIC DATA SHOW CONTINUED NEED FOR ONGOING AND INCREASING EFFORTS IN HIV CARE AND TREATMENT OVERALL. PEOPLE OVER THE AGE OF 45 MAKE UP 42.1% OF ALL PWH AND 33% OF ALL LATE DIAGNOSES. IN 2023, THERE WERE 27,712 PWH IN VIRGINIA, REPRESENTING 0.3% OF THE STATE’S POPULATION AND APPROXIMATELY 2.6% OF THE NATION’S TOTAL NUMBER OF HIV DISEASE CASES. PWH REMAIN RELATIVELY CONSISTENT WITH PREVIOUS TRENDS WITH 75% BEING MALE (20,886), AND THE AGE DISTRIBUTION RATES WERE HIGHEST AMONG THE 45-54 AGE GROUP AT 508.0 PER 100,000, FOLLOWED BY THE AGE GROUP 55+ AT 467.0 PER 100,000 PERSONS. BY RACE, BLACKS COMPRISE 20% OF VIRGINIA’S POPULATION BUT REPRESENT 56.6% OF PWH (N=10,838). THIS IS A DECREASE OF 1.4% SINCE 2020. SEVENTY-TWO PERCENT OF PWH ARE CURRENTLY 40 YEARS OF AGE OR OLDER (N=19,960) AND 41.5% ARE 55 YEARS OF AGE OR OLDER (N=11,504). FURTHER, DIAGNOSES OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AMONG PWH CONTINUE TO BE SIGNIFICANT. DURING 2024, THERE WERE 671 CHLAMYDIA, 947 GONORRHEA AND 878 SYPHILIS (ALL STAGES) DIAGNOSES AMONG PWH IN VIRGINIA. BETWEEN 2015 – 2024, THERE WERE 191 HIV/HEPATITIS C (HCV) COINFECTIONS, AND 115 HIV/HEPATITIS B (HBV) COINFECTIONS (INCLUDING FOUR ACUTE HBV) REPORTED AMONG NEW HIV DIAGNOSES. IN 2019, THERE WERE 39 HIV/VIRAL HEPATITIS COINFECTIONS. DATA SHOW STABLE TRENDS IN HBV AND HCV COINFECTIONS FROM 2021 TO 2024 (36, 36, 38, AND 37 CASES, RESPECTIVELY). VIRGINIA UTILIZES RYAN WHITE-RELATED RESOURCES GENERATED FROM ITS ADAP (I.E. PHARMACEUTICAL REBATES) TO FUND ADDITIONAL RWHAP B CORE MEDICAL AND SUPPORT SERVICES. THE LANDSCAPE FOR GENERATING PHARMACEUTICAL REBATES IS CHANGING AND IMPACTING THE ABILITY TO MAINTAIN THE PROGRAM’S RESPONSIVENESS TO PWH’S NEEDS, THOSE NEEDS IMPACTED BY SOCIAL DETERMINANTS. THE GOAL OF THE SUPPLEMENTAL FUNDS WILL MAINTAIN THE COMPREHENSIVE SYSTEM OF HIV CARE AND TREATMENT MADE AVAILABLE THROUGH THE RWHAP PART B PROGRAM. THE SUPPLEMENTAL FUNDING WILL SUPPORT VIRGINIA’S PWH FOR IMPROVED HEALTH OUTCOMES ALONG THE HIV CARE CONTINUUM AND SUPPORT OTHER GOALS TOWARD VIRGINIA BECOMING THE HEALTHIEST STATE IN THE NATION.
Awardee
Funding Goals
THIS NOTICE ANNOUNCES THE OPPORTUNITY TO APPLY FOR FUNDING UNDER THE RYAN WHITE HIV/AIDS PROGRAM (RWHAP) PART B STATES/TERRITORIES SUPPLEMENTAL GRANT PROGRAM, WHICH INCLUDES THE DISTRICT OF COLUMBIA, THE COMMONWEALTH OF PUERTO RICO, THE VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, THE REPUBLIC OF PALAU, AND THE FEDERATED STATES OF MICRONESIA. THE PURPOSE OF THIS PROGRAM IS TO SUPPLEMENT FORMULA-BASED FUNDING PROVIDED THROUGH THE HIV CARE GRANT PROGRAM RWHAP PART B STATES/TERRITORIES FORMULA AND AIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULA AND ADAP SUPPLEMENTAL AWARDS NOTICE OF FUNDING OPPORTUNITY (HRSA-22-033). STATES/TERRITORIES USE RWHAP PART B SUPPLEMENTAL GRANT PROGRAM FUNDING IN CONJUNCTION WITH RWHAP PART B HIV CARE GRANT PROGRAM FUNDING TO DEVELOP AND/OR ENHANCE ACCESS TO A COMPREHENSIVE CONTINUUM OF HIGH-QUALITY CARE AND TREATMENT SERVICES FOR LOW-INCOME PEOPLE WITH HIV. TO OBTAIN FUNDING, STATES/TERRITORIES MUST DEMONSTRATE THAT RWHAP PART B SUPPLEMENTAL FUNDING IS NECESSARY TO PROVIDE COMPREHENSIVE HIV CARE AND TREATMENT SERVICES FOR PEOPLE WITH HIV IN THE STATE/TERRITORY. PROPOSED ACTIVITIES SHOULD INCLUDE THE PROVISION OF CORE MEDICAL AND/OR SUPPORT SERVICES, AS DEFINED IN HAB POLICY CLARIFICATION NOTICE (PCN) 16-02: RWHAP SERVICES: ELIGIBLE INDIVIDUALS AND ALLOWABLE USES OF FUNDS, AND OTHER ACTIVITIES TO ENSURE RESPONSIVENESS TO UNMET NEEDS. STATES/TERRITORIES MUST DESCRIBE HOW PROPOSED ACTIVITIES WILL ADDRESS UNMET NEEDS AND IMPROVE CLIENT-LEVEL HEALTH OUTCOMES ACROSS THE HIV CARE CONTINUUM, INCLUDING VIRAL SUPPRESSION. ELIGIBLE RWHAP PART B STATES/TERRITORIES THAT ARE FOCUS AREAS, OR HAVE COUNTIES THAT ARE FOCUS AREAS, FOR THE ENDING THE HIV EPIDEMIC IN THE U.S. (EHE) INITIATIVE SHOULD CONSIDER IF THERE IS A DEMONSTRATED NEED FOR RWHAP PART B SUPPLEMENTAL FUNDING DUE TO THE EHE INITIATIVE EFFORTS USING CRITERIA BELOW. AS REQUIRED IN SECTION 2620(B) OF THE PUBLIC HEALTH SERVICE (PHS) ACT, STATES/TERRITORIES MUST DEMONSTRATE THE SEVERITY OF THE NEED FOR RWHAP PART B SUPPLEMENTAL FUNDING USING QUANTIFIABLE DATA IN ONE OR MORE OF THE FOLLOWING AREAS: THE UNMET NEED FOR SUCH SERVICES, AS DETERMINED UNDER SECTION 2617(B) OF THE PHS ACT. AN INCREASING NEED FOR HIV/AIDS-RELATED SERVICES, INCLUDING RELATIVE RATES OF INCREASE IN THE NUMBER OF CASES OF HIV/AIDS. THE RELATIVE RATES OF INCREASE IN THE NUMBER OF CASES OF HIV/AIDS WITHIN NEW OR EMERGING SUBPOPULATIONS. THE CURRENT PREVALENCE OF HIV/AIDS. RELEVANT FACTORS RELATED TO THE COST AND COMPLEXITY OF DELIVERING HEALTH CARE TO INDIVIDUALS WITH HIV/AIDS IN THE ELIGIBLE AREA. THE IMPACT OF CO-MORBID FACTORS, INCLUDING CO-OCCURRING CONDITIONS, DETERMINED RELEVANT BY THE SECRETARY. THE PREVALENCE OF HOMELESSNESS. THE PREVALENCE OF INDIVIDUALS WHO WERE RELEASED FROM FEDERAL, STATE, OR LOCAL PRISONS DURING THE PRECEDING THREE (3) YEARS AND HAD HIV/AIDS ON THE DATE OF THEIR RELEASE. THE RELEVANT FACTORS THAT LIMIT ACCESS TO HEALTH CARE, INCLUDING GEOGRAPHIC VARIATION, ADEQUACY OF HEALTH INSURANCE COVERAGE, AND LANGUAGE BARRIERS. THE IMPACT OF A DECLINE IN THE AMOUNT OF RWHAP PART B FUNDING RECEIVED ON SERVICES AVAILABLE TO ALL INDIVIDUALS WITH HIV/AIDS IDENTIFIED AND ELIGIBLE UNDER THIS TITLE. PURSUANT TO SECTION 2620(C) OF THE PHS ACT, THE SECRETARY PRIORITIZES FUNDS TO STATES/TERRITORIES TO ADDRESS THE REDUCTION OR DISRUPTION OF SERVICES RELATED TO A DECLINE IN THE AMOUNT OF FORMULA FUNDING. SUCH A DECLINE IN FUNDING IS DETERMINED BY COMPARING THE AMOUNT OF FORMULA FUNDING RECEIVED IN THE CURRENT FISCAL YEAR (FY) TO THE AMOUNT RECEIVED IN FY 2006. IF YOU ARE A STATE/TERRITORY WITH CURRENT OR POTENTIAL SHORTFALLS IN AIDS DRUG ASSISTANCE PROGRAM (ADAP) RESOURCES, WE STRONGLY ENCOURAGE YOU TO PRIORITIZE USE OF RWHAP PART B SUPPLEMENTAL FUNDS TO AUGMENT ADAP RESOURCES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Virginia
United States
Geographic Scope
State-Wide
Virginia Department Of Health was awarded
Virginia HIV Care Continuum : Supporting PWH Improved Health Outcomes
Project Grant X0855259
worth $3,800,581
from the HRSA Office of Federal Assistance Management in September 2025 with work to be completed primarily in Virginia United States.
The grant
has a duration of 1 year and
was awarded through assistance program 93.917 HIV Care Formula Grants.
The Project Grant was awarded through grant opportunity Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program.
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
9/30/25
Start Date
9/29/26
End Date
Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
X0855259
SAI Number
X0855259-3938005540
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75RJ00 HRSA Office of Federal Assistance Management
Funding Office
75RV00 HRSA HIV/AIDS BUREAU
Awardee UEI
WD63KVNZEFK8
Awardee CAGE
3PVD3
Performance District
VA-90
Senators
Mark Warner
Timothy Kaine
Timothy Kaine
Modified: 9/24/25